Table 1.
Serum PTH, serum and urinary calcium, and serum phosphorus, alkaline phosphatase, albumin and albumin-corrected calcium levels in control subjects, and in patients of thalassemia receiving packed cell transfusion with and without vitamin D and calcium supplementations
| Parameters | Controls (group I) | Patients (group II) | Patients receiving supplementations (group III) | |
|---|---|---|---|---|
| Before supplementation | 3 Months after supplementation | |||
| PTH (pg/ml) | 44.3 ± 5.63 | 32.2 ± 0.96* | 31.9 ± 2.22* | 33.4 ± 2.07*,** |
| Serum calcium (mg/dl) | 9.98 ± 0.16 | 8.42 ± 0.32* | 8.46 ± 0.33* | 9.78 ± 0.13** |
| Urinary calcium (mg/24 h) | 159 ± 17.0 | 120 ± 2.6* | 119 ± 3.1* | 129 ± 1.8*,** |
| Alkaline phosphatase (KA U/L) | 7.66 ± 0.60 | 7.67 ± 0.85 | 7.64 ± 0.61 | 7.65 ± 0.03 |
| Albumin (g/dl) | 3.53 ± 0.02 | 3.54 ± 0.04 | 3.53 ± 0.11 | 3.55 ± 0.10 |
| Albumin-corrected calcium (mg/dl) | 4.48 ± 0.03 | 4.47 ± 0.01 | 4.47 ± 0.05 | 4.48 ± 0.02 |
Values are mean ± S.E.M. for 15 subjects in each group
* P < 0.05 when compared to group I
** P < 0.05 when compared to the mean value before supplementation (group III)